Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV, Prospective Study of the Safety of GSK Bios' Pediarix Administered to a Cohort of Infants in a US Health Maintenance Organization (HMO). (Post-Marketing PEDIARIX Safety Study)

NCT00146835 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00146835
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00146835 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV, Prospective Study of the Safety of GSK Bios' Pediarix Administered to a Cohort of Infants in a US Health Maintenance Organization (HMO). (Post-Marketing PEDIARIX Safety Study)
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
April 30, 2003
Completion date
June 30, 2006
Enrollment
120,794 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acellular pertussis, diphtheria, hepatitis b, poliomyelitis, tetanus